MicroRNA-486-5p Improves Nonsmall-Cell Lung Cancer Chemotherapy Sensitivity and Inhibits Epithelial–mesenchymal Transition by Targeting Twinfilin Actin Binding Protein 1

Journal of International Medical Research - United Kingdom
doi 10.1177/0300060519850739
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

miR-125a-5p Inhibits Colorectal Cancer Cell Epithelial–mesenchymal Transition, Invasion and Migration by Targeting TAZ

OncoTargets and Therapy
OncologyPharmacology
2019English

microRNA-802 Inhibits Epithelial-Mesenchymal Transition Through Targeting Flotillin-2 in Human Prostate Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

MicroRNA‑139‑5P Inhibits Human Prostate Cancer Cell Proliferation by Targeting Notch1

Oncology Letters
Cancer ResearchOncology
2018English

Apatinib Inhibits Macrophage-Mediated Epithelial–mesenchymal Transition in Lung Cancer

RSC Advances
ChemistryChemical Engineering
2018English

MicroRNA-340-5p Suppresses Non-Small Cell Lung Cancer Cell Growth and Metastasis by Targeting ZNF503

Cellular and Molecular Biology Letters
BiochemistryCell BiologyMolecular Biology
2019English

microRNA-30b/c Inhibits Non-Small Cell Lung Cancer Cell Proliferation by Targeting Rab18

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

MicroRNA‑486‑5p Functions as a Tumor Suppressor of Proliferation and Cancer Stem‑like Cell Properties by Targeting Sirt1 in Liver Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Low Expression of microRNA-30c Promotes Invasion by Inducing Epithelial Mesenchymal Transition in Non-Small Cell Lung Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

miR‑30a Inhibits Epithelial‑mesenchymal Transition and Metastasis in Triple‑negative Breast Cancer by Targeting ROR1

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy